SCHWARTZ AHARON purchased 74.1% of their position (129K shares) of PROTALIX BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $205.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2025ACC: 0001415889-25-021494
Director
Since Jan 2020
+129K
Net shares
Net buyer
$205.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
129K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+129K
Price / share
$1.60
Trade value
$205.88K
% of position
74.1%
6/10/2025
174K→303K
Total
Net shares
+129K
Net value
$205.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2025 | P · Purchase | +129K | $1.60 | $205.88K | 74.1% | 174K | 303K |
| Total | +129K | $205.88K | ||||||
Derivative Transactions0
No derivative transactions reported